Literature DB >> 20399273

Hippocampal pathology in individuals at ultra-high risk for psychosis: a multi-modal magnetic resonance study.

Stephen J Wood1, Damien Kennedy, Lisa J Phillips, Marc L Seal, Murat Yücel, Barnaby Nelson, Alison R Yung, Graeme Jackson, Patrick D McGorry, Dennis Velakoulis, Christos Pantelis.   

Abstract

Although the hippocampus is a key brain region in the pathophysiology of schizophrenia, it is unclear whether structural or biochemical abnormalities predate illness onset. In this study, we used magnetic resonance imaging and spectroscopy data acquired prior to both the onset of psychosis and treatment with antipsychotics to determine this. Sixty-six young people clinically at ultra high-risk of development of psychosis were recruited, 59 of whom did not later develop a psychotic disorder and 7 who had done so after at least 24 months follow-up. These participants were compared with 29 healthy comparison subjects on multiple independent magnetic resonance measures: hippocampal volume, hippocampal T2 relaxation time, and medial temporal lobe metabolite concentrations (including N-acetylaspartate). We found similar reductions in left hippocampal volume in the at-risk group compared to comparison subjects regardless of later transition status; on the right this only reached significance for the at-risk group who did not transition to psychosis. T2 relaxation time in the left hippocampal head was significantly elevated in the later-psychotic group, and this elevation positively correlated with total positive symptoms in the UHR group as a whole. Medial temporal lobe metabolite concentrations did not differ. These findings suggest that there are subtle pathological changes in the hippocampus prior to the development of psychosis, but that they are limited to the left hippocampal head. However, standard measures of neuroanatomical disturbance do not appear to be predictive of later transition, and instead are likely to be non-specific and common in cases that later develop a non-psychotic disorder. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20399273     DOI: 10.1016/j.neuroimage.2010.04.012

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  47 in total

Review 1.  Glutamate-mediated excitotoxicity in schizophrenia: a review.

Authors:  Eric Plitman; Shinichiro Nakajima; Camilo de la Fuente-Sandoval; Philip Gerretsen; M Mallar Chakravarty; Jane Kobylianskii; Jun Ku Chung; Fernando Caravaggio; Yusuke Iwata; Gary Remington; Ariel Graff-Guerrero
Journal:  Eur Neuropsychopharmacol       Date:  2014-08-01       Impact factor: 4.600

Review 2.  Age of onset of schizophrenia: perspectives from structural neuroimaging studies.

Authors:  Nitin Gogtay; Nora S Vyas; Renee Testa; Stephen J Wood; Christos Pantelis
Journal:  Schizophr Bull       Date:  2011-05       Impact factor: 9.306

Review 3.  Preclinical (1)H-MRS neurochemical profiling in neurological and psychiatric disorders.

Authors:  Moonnoh R Lee; Aleksandar Denic; David J Hinton; Prasanna K Mishra; Doo-Sup Choi; Istvan Pirko; Moses Rodriguez; Slobodan I Macura
Journal:  Bioanalysis       Date:  2012-07       Impact factor: 2.681

Review 4.  Gray matter alterations in schizophrenia high-risk youth and early-onset schizophrenia: a review of structural MRI findings.

Authors:  Benjamin K Brent; Heidi W Thermenos; Matcheri S Keshavan; Larry J Seidman
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2013-07-23

5.  Biomarkers and clinical staging in psychiatry.

Authors:  Patrick McGorry; Matcheri Keshavan; Sherilyn Goldstone; Paul Amminger; Kelly Allott; Michael Berk; Suzie Lavoie; Christos Pantelis; Alison Yung; Stephen Wood; Ian Hickie
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

Review 6.  Kraepelin revisited: schizophrenia from degeneration to failed regeneration.

Authors:  P Falkai; M J Rossner; T G Schulze; A Hasan; M M Brzózka; B Malchow; W G Honer; A Schmitt
Journal:  Mol Psychiatry       Date:  2015-03-31       Impact factor: 15.992

7.  Maternal-fetal blood incompatibility and neuromorphologic anomalies in schizophrenia: Preliminary findings.

Authors:  David Freedman; Raymond Deicken; Lawrence S Kegeles; Sophia Vinogradov; Yuanyuan Bao; Alan S Brown
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-05-03       Impact factor: 5.067

8.  Structural abnormalities in the cuneus associated with Herpes Simplex Virus (type 1) infection in people at ultra high risk of developing psychosis.

Authors:  Thomas J Whitford; Stephen J Wood; Alison Yung; Luca Cocchi; Gregor Berger; Martha E Shenton; Marek Kubicki; Lisa Phillips; Dennis Velakoulis; Robert H Yolken; Christos Pantelis; Patrick McGorry; G Paul Amminger
Journal:  Schizophr Res       Date:  2012-01-12       Impact factor: 4.939

9.  Intact relational memory and normal hippocampal structure in the early stage of psychosis.

Authors:  Lisa E Williams; Suzanne N Avery; Austin A Woolard; Stephan Heckers
Journal:  Biol Psychiatry       Date:  2011-11-04       Impact factor: 13.382

Review 10.  Structural brain alterations in individuals at ultra-high risk for psychosis: a review of magnetic resonance imaging studies and future directions.

Authors:  Wi Hoon Jung; Joon Hwan Jang; Min Soo Byun; Suk Kyoon An; Jun Soo Kwon
Journal:  J Korean Med Sci       Date:  2010-11-24       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.